These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 17308072

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
    Fraser M, Bai T, Tsang BK.
    Int J Cancer; 2008 Feb 01; 122(3):534-46. PubMed ID: 17918180
    [Abstract] [Full Text] [Related]

  • 27. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G, Knape I, Melzner I, Debatin KM.
    J Immunol; 2003 Aug 01; 171(3):1172-82. PubMed ID: 12874203
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
    Yang X, Fraser M, Moll UM, Basak A, Tsang BK.
    Cancer Res; 2006 Mar 15; 66(6):3126-36. PubMed ID: 16540663
    [Abstract] [Full Text] [Related]

  • 31. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.
    Sankpal UT, Ingersoll SB, Ahmad S, Holloway RW, Bhat VB, Simecka JW, Daniel L, Kariali E, Vishwanatha JK, Basha R.
    Tumour Biol; 2016 Oct 15; 37(10):14259-14269. PubMed ID: 27581819
    [Abstract] [Full Text] [Related]

  • 32. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
    Kamarajan P, Sun NK, Chao CC.
    Biochem J; 2003 Nov 15; 376(Pt 1):253-60. PubMed ID: 12911332
    [Abstract] [Full Text] [Related]

  • 33. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA, Sabaa BE, Abdelkhalik D, Mansour H, Melis M, Shaalan W, Farouk M, Malik E, Soliman AA.
    J Cancer Res Clin Oncol; 2016 May 15; 142(5):949-58. PubMed ID: 26762850
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Elafin selectively regulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.
    Wei H, Hellström KE, Hellström I.
    Gynecol Oncol; 2012 Jun 15; 125(3):727-33. PubMed ID: 22430613
    [Abstract] [Full Text] [Related]

  • 36. Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.
    Moraya AI, Ali JL, Samadder P, Liang L, Morrison LC, Werbowetski-Ogilvie TE, Ogunsina M, Schweizer F, Arthur G, Nachtigal MW.
    J Exp Clin Cancer Res; 2017 May 12; 36(1):67. PubMed ID: 28499442
    [Abstract] [Full Text] [Related]

  • 37. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
    Milner AE, Palmer DH, Hodgkin EA, Eliopoulos AG, Knox PG, Poole CJ, Kerr DJ, Young LS.
    Cell Death Differ; 2002 Mar 12; 9(3):287-300. PubMed ID: 11859411
    [Abstract] [Full Text] [Related]

  • 38. Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway.
    Lee CS, Jang ER, Kim YJ, Myung SC, Kim W, Lee MW.
    Invest New Drugs; 2012 Apr 12; 30(2):548-57. PubMed ID: 21120579
    [Abstract] [Full Text] [Related]

  • 39. 18β-glycyrrhetinic acid potentiates Hsp90 inhibition-induced apoptosis in human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathway.
    Yang JC, Myung SC, Kim W, Lee CS.
    Mol Cell Biochem; 2012 Nov 12; 370(1-2):209-19. PubMed ID: 22865487
    [Abstract] [Full Text] [Related]

  • 40. PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway.
    Yang X, Zhang Q, Yang X, Zhao M, Yang T, Yao A, Tian X.
    Biochem Biophys Res Commun; 2019 Apr 16; 511(4):719-724. PubMed ID: 30827507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.